Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Justera Health Ltd C.VTAL

Alternate Symbol(s):  SCRSF

Justera Health Ltd. is a Canadian company focused on health and wellness. It offers personalized healthcare services and solutions, such as IV Vitamin Therapy, premium nutritional supplements through its Naturevan Nutrition brand, a full 360-degree wellness and spa experience through Juillet Wellness that provides registered massage therapy, acupuncture, and new retail stores in Vancouver. Its... see more

CSE:VTAL - Post Discussion

Justera Health Ltd > Getting it Straight
View:
Post by Smokey1958 on Sep 20, 2021 5:56am

Getting it Straight

The relationship between DM and SCRN is open and without dispute. DM was never in the business of carrying out the tests they were securing the rights to buy and distribute. It's no coincidence that the tests SCRN was selling and processing just happened to be from South Korea ...the same as those procured and sold by DM.

This from the first NR associated with SCRN becoming a public company.

ScreenPro provides turnkey coronavirus screening solutions to the private sector. ScreenPro's unique access to multiple manufacturers of high quality South Korean test kits and its strategic partnership with Canvas Labs in Vancouver and Integrated Explorations in Ontario.

There was also the relationship between DM and SCRN for the walk-in clinic (Concierge Medical - subsidiary of DM) in Vancouver. It would be no surprise to learn the ScreenPro had been carrying out the testing and processing of the tests sold by DM long before it became a public entity.

None of this takes away from anything happening with ScreenPro in terms of tests completed and revenue generated. DM NRs refer to the contracts (relationships) signed and the tests sold while SCRN NRs deal specifically with tests completed ....and there has been no deviation away from this. The only difference now is that one could expect that SCRN is a middleman in the sale of test kits and is the service provider for carrying out these tests. That is for every test device sold by DM as per their NRs SCRN is a significant partner.

The result is clear and unequivocal .....$6.8 million in revenue for Q1 and $5.6 million in Q2 with addional film companies and productions in the pipeline for Q3 .....and NO discernible END to testing, testing, testing. Further to that Morningstar's Fair Value sp has never fallen below $.04. Their 1-star speculative valuation has been between $.08 and $.11 for over a month.

Imho, were it not for constant and determined manipulation of the sp of SCRN by day traders the irrational sp over the last week and several months now would be a distant memory. As such it would and should not take much to finally see this debacle behind us.

GLTE ....holding patiently!!!
Comment by MyAli4s on Sep 20, 2021 8:57am
This post has been removed in accordance with Community Policy
Comment by Smokey1958 on Sep 20, 2021 9:17am
There is not ONE scenario or shred of evidence you could produce or articulate that explains how individuals who got shares when the company went public or acquired GoStop could have BOTH caused this and continue to do so. While the initial dumping of shares would have taken the sp from $1.00 to a more reasonable valuation of $.10 all analyses and financials presented thus far should see the sp at ...more  
Comment by MyAli4s on Sep 20, 2021 9:38am
This post has been removed in accordance with Community Policy
Comment by MyAli4s on Sep 20, 2021 9:57am
This post has been removed in accordance with Community Policy
Comment by Smokey1958 on Sep 20, 2021 10:25am
I included the GoStop shares as part of my post. They were sold long ago ....rest assured. As for the volume of outstanding shares since inception ....yes you need to compare ....to other companies both within and outside of this sector with similar volumes. There are many that have a significantly higher sp and have not made a cent. As for selling, the majority of those selling are investors who, ...more  
Comment by MyAli4s on Sep 20, 2021 10:31am
This post has been removed in accordance with Community Policy
Comment by Smokey1958 on Sep 20, 2021 10:50am
You still didn't answer the question. You have every right as a legitimate investor to have opinions on management and the sp ....my question was are you invested in ScreenPro? As for bad management, I was more than happy to put the blame on John McMullen for throwing out vague, and as it turned out, false narratives on the number of tests completed and the revenue generated from those ...more  
Comment by MyAli4s on Sep 20, 2021 2:08pm
This post has been removed in accordance with Community Policy
Comment by Smokey1958 on Sep 20, 2021 2:39pm
This post has been removed in accordance with Community Policy
Comment by JWING17 on Sep 20, 2021 3:02pm
This post has been removed in accordance with Community Policy
Comment by Charleyfarley on Sep 20, 2021 3:19pm
This post has been removed in accordance with Community Policy
Comment by MyAli4s on Sep 20, 2021 10:37am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities